JP2017505327A5 - - Google Patents

Download PDF

Info

Publication number
JP2017505327A5
JP2017505327A5 JP2016550611A JP2016550611A JP2017505327A5 JP 2017505327 A5 JP2017505327 A5 JP 2017505327A5 JP 2016550611 A JP2016550611 A JP 2016550611A JP 2016550611 A JP2016550611 A JP 2016550611A JP 2017505327 A5 JP2017505327 A5 JP 2017505327A5
Authority
JP
Japan
Prior art keywords
oxy
pyridin
trifluoromethyl
alkyl
quinolin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016550611A
Other languages
English (en)
Japanese (ja)
Other versions
JP6532474B2 (ja
JP2017505327A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/014380 external-priority patent/WO2015119998A1/en
Publication of JP2017505327A publication Critical patent/JP2017505327A/ja
Publication of JP2017505327A5 publication Critical patent/JP2017505327A5/ja
Application granted granted Critical
Publication of JP6532474B2 publication Critical patent/JP6532474B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016550611A 2014-02-06 2015-02-04 6−ヘテロアリールオキシ−および6−アリールオキシ−キノリン−2−カルボキシアミドならびにその使用 Expired - Fee Related JP6532474B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461936397P 2014-02-06 2014-02-06
US61/936,397 2014-02-06
PCT/US2015/014380 WO2015119998A1 (en) 2014-02-06 2015-02-04 6-heteroaryloxy- and 6-aryloxy-quinoline-2-carboxamides and uses thereof

Publications (3)

Publication Number Publication Date
JP2017505327A JP2017505327A (ja) 2017-02-16
JP2017505327A5 true JP2017505327A5 (cg-RX-API-DMAC7.html) 2018-03-15
JP6532474B2 JP6532474B2 (ja) 2019-06-19

Family

ID=52484589

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016550611A Expired - Fee Related JP6532474B2 (ja) 2014-02-06 2015-02-04 6−ヘテロアリールオキシ−および6−アリールオキシ−キノリン−2−カルボキシアミドならびにその使用

Country Status (14)

Country Link
US (3) US9452986B2 (cg-RX-API-DMAC7.html)
EP (1) EP3102569A1 (cg-RX-API-DMAC7.html)
JP (1) JP6532474B2 (cg-RX-API-DMAC7.html)
KR (1) KR20160118345A (cg-RX-API-DMAC7.html)
CN (1) CN106458985B (cg-RX-API-DMAC7.html)
AU (1) AU2015214366B2 (cg-RX-API-DMAC7.html)
BR (1) BR112016017996A2 (cg-RX-API-DMAC7.html)
CA (1) CA2938719A1 (cg-RX-API-DMAC7.html)
HK (1) HK1231471A1 (cg-RX-API-DMAC7.html)
IL (1) IL247014A0 (cg-RX-API-DMAC7.html)
MX (1) MX2016010056A (cg-RX-API-DMAC7.html)
RU (1) RU2016135637A (cg-RX-API-DMAC7.html)
SG (1) SG11201606367YA (cg-RX-API-DMAC7.html)
WO (1) WO2015119998A1 (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201444849A (zh) 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代的7-氮雜雙環類及其作為食慾激素受體調節劑之用途
TWI621618B (zh) 2013-03-13 2018-04-21 比利時商健生藥品公司 經取代2-氮雜雙環類及其作為食慾素受體調控劑之用途
TW201444821A (zh) 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代之哌啶化合物及其作為食慾素受體調節劑之用途
PT3805233T (pt) 2014-01-13 2024-04-15 Aurigene Oncology Ltd Enantiómeros (r) e (s) de n-(5-(3-hidroxipirrolidin-1-il)-2 morfolinooxazolo[4,5-b]piridin-6-il)-2-(2-metilpiridin-4-il)oxazole-carboxamida como inibidores de irak4 para o tratamento de cancro
KR20160118345A (ko) * 2014-02-06 2016-10-11 애브비 인코포레이티드 6-헤테로아릴옥시- 및 6-아릴옥시-퀴놀린-2-카복사미드 및 이의 용도
MX2016017147A (es) * 2014-06-20 2017-06-07 Aurigene Discovery Tech Ltd Compuestos de indazole substituidos como inhibidores de irak4.
MX2017003254A (es) * 2014-09-11 2017-10-12 Janssen Pharmaceutica Nv 2-azabiciclos sustituidos y su uso como moduladores de receptores de orexina.
EP3359151A4 (en) 2015-10-07 2019-08-14 Arizona Board of Regents on behalf of the University of Arizona CRMP2 SUMOYLATION INHIBITORS AND USES THEREOF
CN108513574B (zh) * 2015-10-09 2021-01-05 艾伯维公司 N-磺酰化吡唑并[3,4-b]吡啶-6-甲酰胺和使用方法
BR112019012822A2 (pt) 2016-12-22 2019-11-26 Bayer Ag 1,2,4-tiadiazolilpirrolonas e 1,2,4-tiadiazolil-hidantoínas e sais das mesmas e uso das mesmas como herbicidas
CA3056893A1 (en) 2017-03-31 2018-10-04 Aurigene Discovery Technologies Limited Compounds and compositions for treating hematological disorders
PL3615527T3 (pl) * 2017-06-30 2024-07-01 Elanco Animal Health Gmbh Nowe pochodne azachinoliny
RS65572B1 (sr) 2017-10-31 2024-06-28 Curis Inc Inhibitor irak4 u kombinaciji sa inhibitorom bcl-2 za upotrebu u lečenju kancera
US12234221B2 (en) 2018-07-09 2025-02-25 Lieber Institute, Inc. Pyridine carboxamide compounds for inhibiting NAV1.8
CA3105748A1 (en) 2018-07-09 2020-01-16 Lieber Institute, Inc. Pyridazine compounds for inhibiting nav1.8
KR102812440B1 (ko) 2018-09-10 2025-05-26 가껭세이야꾸가부시기가이샤 신규한 헤테로방향족 아미드 유도체 및 이를 함유하는 약제
BR112021008741A2 (pt) 2018-11-09 2021-08-10 Vivace Therapeutics, Inc. compostos bicíclicos
US11976052B2 (en) * 2019-01-11 2024-05-07 Naegis Pharmaceuticals Inc. Leukotriene synthesis inhibitors
TWI849107B (zh) * 2019-04-16 2024-07-21 美商維瓦斯治療公司 雙環化合物
US12178821B2 (en) 2021-04-08 2024-12-31 Curis, Inc. Combination therapies for the treatment of cancer
KR20240134944A (ko) * 2022-01-18 2024-09-10 쳉두 캉홍 파마슈티칼 코., 엘티디. 방향족 융합 고리 nav1.8 억제제 및 이의 용도
TW202434557A (zh) 2022-11-09 2024-09-01 瑞士商先正達農作物保護股份公司 殺微生物之吡唑衍生物
WO2025078263A1 (en) 2023-10-11 2025-04-17 Syngenta Crop Protection Ag Microbiocidal pyridyl pyrazole derivatives
WO2025233384A1 (en) 2024-05-08 2025-11-13 Syngenta Crop Protection Ag Microbiocidal pyrazole compounds

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1663994B1 (en) 2003-08-05 2012-03-07 Vertex Pharmaceuticals Incorporated Tetrahydroquinazoline compounds as inhibitors of voltage-gated ion channels
CN101044135B (zh) * 2004-10-19 2011-11-23 霍夫曼-拉罗奇有限公司 喹啉衍生物
RU2007146769A (ru) * 2005-05-16 2009-06-27 Вертекс Фармасьютикалз Инкорпорейтед (Us) Бициклические производные и их применение в качестве модуляторов ионых каналов
GB0513692D0 (en) * 2005-07-04 2005-08-10 Karobio Ab Novel pharmaceutical compositions
EP1924565B1 (en) * 2005-09-01 2016-09-14 F.Hoffmann-La Roche Ag Diaminopyrimidines as p2x3 and p3x2/3 modulators
EP2046799B1 (en) 2006-04-26 2017-07-19 Genentech, Inc. Phosphoinositide 3-kinase inhibitor compounds and pharmaceutical compositions containing them
BRPI0719210A2 (pt) * 2006-10-12 2015-05-05 Xenon Pharmaceuticals Inc Uso de compostos espiro-oxindol como agentes terapêuticos
SA08290245B1 (ar) * 2007-04-23 2012-02-12 استرازينيكا ايه بي مشتقات كربو كساميد جديدة من -n (8-اريل رباعي هيدرو نفثالين غير متجانس- 2- يل) أو -n (5-اريل كرومان غير متجانس -3-يل) لعلاج الألم
CN102448937A (zh) 2009-05-29 2012-05-09 拉夸里亚创药株式会社 作为钙或钠通道阻滞剂的芳基取代羧酰胺衍生物
WO2011058766A1 (en) * 2009-11-16 2011-05-19 Raqualia Pharma Inc. Aryl carboxamide derivatives as ttx-s blockers
EP2569285A1 (en) * 2010-05-10 2013-03-20 Gilead Sciences, Inc. Bifunctional quinoline derivatives
WO2012053186A1 (en) * 2010-10-18 2012-04-26 Raqualia Pharma Inc. Arylamide derivatives as ttx-s blockers
AU2014212426B8 (en) 2013-01-31 2018-05-10 Vertex Pharmaceuticals Incorporated Quinoline and Quinoxaline Amides as Modulators of Sodium Channels
KR20160118345A (ko) * 2014-02-06 2016-10-11 애브비 인코포레이티드 6-헤테로아릴옥시- 및 6-아릴옥시-퀴놀린-2-카복사미드 및 이의 용도

Similar Documents

Publication Publication Date Title
JP2017505327A5 (cg-RX-API-DMAC7.html)
RU2016135637A (ru) 6-гетероарилокси- и 6-арилоксихинолин-2-карбоксамиды и их применение
US10988478B1 (en) Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators
TWI879728B (zh) Shp2磷酸酶抑制劑及其使用方法
ES2548532T3 (es) Compuestos de pirrolopirimidina como inhibidores de CDK4/6
JP2014506929A5 (cg-RX-API-DMAC7.html)
WO2023018812A1 (en) Heterocyclic compounds and methods of use
AU2022265682A1 (en) 2-aminobenzothiazole compounds and methods of use thereof
AR119209A1 (es) DERIVADOS DE PIRROLO[1,2-c]IMIDAZOL COMO INHIBIDORES DE EGFR
JP2015526394A5 (cg-RX-API-DMAC7.html)
HRP20210177T1 (hr) Supstituirani spojevi pirazolo[1,5-a]piridina kao inhibitori ret kinaze
JP2015537010A5 (cg-RX-API-DMAC7.html)
US20250163064A1 (en) Quinazoline compounds and uses thereof as inhibitors of mutant kras proteins
JP2015522002A5 (cg-RX-API-DMAC7.html)
RU2014123316A (ru) Ингибиторы фосфодиэстеразы типа 10а
JP2014534976A5 (cg-RX-API-DMAC7.html)
JP2018530557A5 (cg-RX-API-DMAC7.html)
JP2017524007A5 (cg-RX-API-DMAC7.html)
CN111655695B (zh) 作为pde1抑制剂的取代的呋喃并嘧啶化合物
JP2015533822A5 (cg-RX-API-DMAC7.html)
JP2019530739A5 (cg-RX-API-DMAC7.html)
RU2015122895A (ru) Пуриновые ингибиторы человеческой фосфатидилинозит 3-киназы дельта
JPWO2020181283A5 (cg-RX-API-DMAC7.html)
KR20190088485A (ko) Gaba a 알파5 pam으로서 신규한 이소옥사졸릴 에터 유도체
JP2021504380A5 (cg-RX-API-DMAC7.html)